Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Systematic In Vivo Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung Adenocarcinoma.

Authors: Walter, David M; Venancio, Olivia S; Buza, Elizabeth L; Tobias, John W; Deshpande, Charuhas; Gudiel, A Andrea; Kim-Kiselak, Caroline; Cicchini, Michelle; Yates, Travis J; Feldser, David M

Published In Cancer Res, (2017 04 01)

Abstract: Chromatin-modifying genes are frequently mutated in human lung adenocarcinoma, but the functional impact of these mutations on disease initiation and progression is not well understood. Using a CRISPR-based approach, we systematically inactivated three of the most commonly mutated chromatin regulatory genes in two KrasG12D-driven mouse models of lung adenocarcinoma to characterize the impact of their loss. Targeted inactivation of SWI/SNF nucleosome-remodeling complex members Smarca4 (Brg1) or Arid1a had complex effects on lung adenocarcinoma initiation and progression. Loss of either Brg1 or Arid1a were selected against in early-stage tumors, but Brg1 loss continued to limit disease progression over time, whereas loss of Arid1a eventually promoted development of higher grade lesions. In contrast to these stage-specific effects, loss of the histone methyltransferase Setd2 had robust tumor-promoting consequences. Despite disparate impacts of Setd2 and Arid1a loss on tumor development, each resulted in a gene expression profile with significant overlap. Setd2 inactivation and subsequent loss of H3K36me3 led to the swift expansion and accelerated progression of both early- and late-stage tumors. However, Setd2 loss per se was insufficient to overcome a p53-regulated barrier to malignant progression, nor establish the prometastatic cellular states that stochastically evolve during lung adenocarcinoma progression. Our study uncovers differential and context-dependent effects of SWI/SNF complex member loss, identifies Setd2 as a potent tumor suppressor in lung adenocarcinoma, and establishes model systems to facilitate further study of chromatin deregulation in lung cancer. Cancer Res; 77(7); 1719-29. ©2017 AACR.

PubMed ID: 28202515 Exiting the NIEHS site

MeSH Terms: Adenocarcinoma of Lung; Adenocarcinoma/etiology; Adenocarcinoma/prevention & control*; Animals; Chromatin/physiology*; Clustered Regularly Interspaced Short Palindromic Repeats; DNA Helicases/physiology; DNA-Binding Proteins; HEK293 Cells; Histone-Lysine N-Methyltransferase/physiology*; Humans; Lung Neoplasms/etiology; Lung Neoplasms/prevention & control*; Mice; Mice, Inbred C57BL; Mutation; Nuclear Proteins/physiology; Proto-Oncogene Proteins p21(ras)/genetics; Transcription Factors/physiology; Tumor Suppressor Protein p53/physiology; Tumor Suppressor Proteins/physiology*

to Top